BioSpace News Archive

Drug Development

CureVac Begins Phase IIb/III Trial of Its mRNA COVID-19 Vaccine

Germany’s CureVac announced it has enrolled the first volunteer in the pivotal Phase IIb/III trial of its own mRNA vaccine candidate, CVnCoV against COVID-19.

December 14, 2020
·
3 min read
·
Mark Terry
BioCapital

Ready, Set, Vaccinate! First COVID-19 Vaccines Administered Today in U.S.

145 hospitals and clinics received their first batch of Pfizer-BioNTech’s coronavirus vaccine today.

December 14, 2020
·
3 min read
·
Kate Goodwin
Business

Long-Tenured MassBio CEO Robert Coughlin Steps Down, Extols Industry’s Accelerated Growth

Robert Coughlin announced in an open letter on Monday that he is leaving the Massachusetts Biotechnology Council (MassBio) following a 13-year tenure as the organization’s president and CEO.

December 14, 2020
·
2 min read
·
Brandon May
Career Advice

3 Ways to Set Boundaries When You Work from Home

Some semblance of a work-life balance is already a challenge to maintain, but doing so when you’re working and living in the same space takes effort and one (or more!) of these strategies.

December 14, 2020
·
2 min read
·
Laura Brothers
Biotech Bay

Eureka’s InvisiMask™ Anti-SARS-CoV-2 Nasal Spray Protects for 10 Hours in Preclinical Results

Eureka Therapeutics’ InvisiMask™ Human Antibody Nasal Spray can provide 10 hours of protection from SARS-CoV-2 virus in animal models, according to preclinical results released today. Now it’s heading to clinical trials.

December 14, 2020
·
5 min read
·
Gail Dutton
Deals

AstraZeneca Dives into Rare Diseases With $39 Billion Acquisition of Alexion

The deal has been approved by both companies’ boards and is expected to close in the third quarter of 2021.

December 14, 2020
·
3 min read
·
Mark Terry
Business

Relay Therapeutics Passes Baton to Genentech for Development of Tumor Treatment

Relay Therapeutics announced today that it has entered a global license and collaboration agreement with Genentech for the commercialization and development of RLY-1971.

December 14, 2020
·
3 min read
·
Krystle Vermes
Biotech Beach

Locanabio Raises $100 Million to Advance RNA-Targeted Gene Therapies

San Diego-based Locanabio secured $100 million in a Series B financing round that will be used to advance the company’s portfolio of novel RNA-targeted gene therapies for neurodegenerative, neuromuscular and retinal diseases.

December 14, 2020
·
2 min read
·
Alex Keown
Drug Development

Incyte and Novartis’ Jakafi Fails to Reduce COVID-19 Associated Cytokine Storm Complications

Incyte and Novartis announced a Phase III study of Jakafi (ruxolitinib), a first-in-class JAK1/JAK2 inhibitor, failed to hit endpoints as a treatment for patients 12 and up with COVID-19 associated cytokine storm.

December 14, 2020
·
2 min read
·
Alex Keown
Pharma and Healthcare Social Media Marketing Market: Notable Developments & Geographical Outlook

Pharma and healthcare social media marketing is an area that is extremely relevant to the modern, digital age, where stakeholders in the pharmaceuticals and healthcare industries are reaching out to their potential customers through digital, social media platforms.

December 14, 2020
·
5 min read